Search
for
Sort by
Research 30 of 1000+
- PD49-02 MEDICATIONS MOST COMMONLY ASSOCIATED WITH ERECTILE DYSFUNCTION: EVALUATION OF THE FOOD AND DRUG ADMINISTRATION NATIONAL PHARMACOVIGILANCE DATABASE
- Medications Most Commonly Associated With Erectile Dysfunction: Evaluation of the Food and Drug Administration National Pharmacovigilance Database
- Organic Causes of Erectile Dysfunction in Men Under 40
- Sexual dysfunction in men taking systemic dermatologic medication: A systematic review
- The adverse effects of commonly used medications on male fertility: a comprehensive review
- Cutting Costs, Not Care: New Models for Affordable Men’s Health Medications
- (163) Cutting Costs, Not Care: New Models for Affordable Men’s Health Medications
- Persistent Erectile Dysfunction after Discontinuation of 5-Alpha Reductase Inhibitor Therapy in Rats Depending on the Duration of Treatment
- Health Warnings Can Boost Sales: Regulators Beware
- Diagnostic criteria for enduring sexual dysfunction after treatment with antidepressants, finasteride and isotretinoin
- Topical Minoxidil 5% Induced Male Sexual Dysfunction
- Adverse Side Effects of 5α‐Reductase Inhibitors Therapy: Persistent Diminished Libido and Erectile Dysfunction and Depression in a Subset of Patients
- Erectile Dysfunction in Young Men—A Review of the Prevalence and Risk Factors
- COMPARISON OF FINASTERIDE AND ALPHA‐BLOCKERS AS INDEPENDENT RISK FACTORS FOR ERECTILE DYSFUNCTION
- Re: Risk of Erectile Dysfunction Associated with Use of 5α-Reductase Inhibitors for Benign Prostatic Hyperplasia or Alopecia: Population Based Studies Using the Clinical Practice Research Datalink
- Approaching Erectile Dysfunction in Dermatology Patients
- The 2018 Revision to the Process of Care Model for Evaluation of Erectile Dysfunction
- Impact of Alpha Blockers, 5-alpha Reductase Inhibitors and Combination Therapy on Sexual Function
- Post-Finasteride Syndrome: An Underestimated Phenomenon
- Association of 5-α reductase inhibitors and sexual dysfunction: A RADAR report
- 5‐Alpha reductase inhibitor related litigation: A legal database review
- Pharma in the bedroom . . . and the kitchen. . . . The pharmaceuticalisation of daily life
- Persistent Sexual Side Effects of Finasteride for Male Pattern Hair Loss
- Efficacy and safety of oral finasteride <i>versus</i> dutasteride in moderate-to-severe androgenetic alopecia in males based on trichoscopic and laboratory findings: a clinical comparison in Iran
- Persistent Sexual, Emotional, and Cognitive Impairment Post-Finasteride
- Sustainable UV approaches supported by greenness and whiteness assessments for estimating a recently FDA-approved combination for managing urologic disorders: Tukey's test
- Beliefs and counseling practices among dermatologists regarding sexual and other adverse effects of finasteride
- Long-term treatment with finasteride: sexual adverse events and fracture rates
- First reboxetine trial results reported
- Faculty Opinions recommendation of Dutasteride improves male pattern hair loss in a randomized study in identical twins.